You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Hemlibra
Hemlibra (generic name: emicizumab-kxwh) is a medication used for the treatment of hemophilia A, a genetic bleeding disorder caused by a deficiency of clotting factor VIII. Hemlibra is a monoclonal antibody that mimics the function of factor VIII, allowing for improved blood clotting. It is used in patients with hemophilia A, including those with inhibitors to factor VIII, and helps reduce the frequency of bleeding episodes.
Oops! We currently don’t have the pricing information for this drug.
But we're continually improving our service to help you save and earn rebates on your medications. If your drug isn't listed on NiHowdy, you can still present your NiHowdy savings card at the pharmacy. We'll work to secure any eligible rebates for that drug and pass the savings back to you retroactively.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
Frequently Asked Questions
How long does it take for Hemlibra to work?
Patients may start to see a reduction in bleeding episodes within a few weeks of starting Hemlibra, but optimal effects may take longer.
Can Hemlibra be taken during pregnancy?
Hemlibra should be used during pregnancy only if the benefits outweigh the risks. Consult your healthcare provider for personalized advice.
What should I do if I miss a dose of Hemlibra?
If you miss a dose, administer it as soon as you remember. If it’s close to the time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
Are there any special storage requirements for Hemlibra?
Store Hemlibra in the refrigerator. Do not freeze. It can be stored at room temperature for a limited time before use; check the product information for specific details.
Is Hemlibra safe for long-term use?
Hemlibra can be safe for long-term use under the supervision of a healthcare provider, with regular monitoring for potential side effects and effectiveness in managing hemophilia A.
Comprehensive Drug Guide
How Does Hemlibra Work?
- Binding to factor IXa and factor X: It bridges the gap between these two clotting factors, mimicking the function of factor VIII, which facilitates the conversion of factor X to activated factor X (Xa).
- Enhancing coagulation: This mechanism improves the body's ability to form clots and helps prevent or reduce bleeding episodes in patients with hemophilia A.
Common Dosages
- Loading dose: 3 mg/kg subcutaneously once weekly for the first 4 weeks.
- Maintenance dose: After the loading dose, the maintenance dosage can be either:
- 1.5 mg/kg subcutaneously every week, or
- 3 mg/kg subcutaneously every two weeks, or
- 6 mg/kg subcutaneously every four weeks.
Typical Dosing
- For prophylaxis: The recommended initial loading dose is 3 mg/kg administered weekly for 4 weeks, followed by a maintenance dose of either 1.5 mg/kg weekly, 3 mg/kg every two weeks, or 6 mg/kg every four weeks, based on patient preference and clinical response.
Typical Dosing
FDA Approved Indications
- Prophylaxis of bleeding episodes in patients with hemophilia A, including those with or without factor VIII inhibitors.
Who Shouldn't Take Hemlibra?
- Known hypersensitivity to emicizumab or any components of the formulation.
- Active thromboembolic disorders, as increased risk of thrombosis may occur.
Advice From The Pharmacist
- Administer Hemlibra subcutaneously as directed, rotating injection sites to avoid irritation.
- Monitor for signs of bleeding and report any unusual bleeding episodes or reactions to your healthcare provider.
- Ensure regular follow-up appointments to assess treatment effectiveness and adjust dosages if necessary.
Side Effects of Hemlibra
Common Side Effects
- Injection site reactions (redness, swelling, pain, or itching)
- Headache
- Fatigue
- Nausea
Uncommon/Severe Side Effects
- Thrombotic microangiopathy (TMA), which can lead to serious complications like kidney problems.
- Serious allergic reactions (such as rash, itching, swelling, or difficulty breathing).
Risks and Warnings of Hemlibra
- Thrombotic Risk: Monitor for signs of thrombosis, especially in patients with other risk factors for thromboembolic events.
- Bleeding Monitoring: While Hemlibra reduces bleeding episodes, regular monitoring for bleeding and coagulation status is recommended.
- Patient Education: Patients should be informed about the signs and symptoms of serious adverse reactions and the importance of adhering to prescribed treatment.
Interactions with Hemlibra
Common Drug Interactions
- Factor VIII products: Caution should be exercised when using Hemlibra with factor VIII concentrates, as there may be an increased risk of thrombotic events.
- Other medications affecting coagulation: Inform your healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential interactions.
Alternatives to Hemlibra
- Factor VIII replacement therapy: Such as recombinant factor VIII products for patients with hemophilia A.
- Emicizumab: Other formulations or alternative treatments for hemophilia management based on individual patient needs.
